Cagrilintide + Semaglutide Blend
Research Peptide | Lyophilized Powder | Batch Tested
For laboratory research use only. Not for human or animal consumption. Insulated shipping · Styrofoam box available.
Product Overview
This blend pairs the long-acting amylin analog cagrilintide with the GLP-1 agonist semaglutide — a "CagriSema"-style combination — for advanced metabolic research into complementary satiety pathways.
No published certificates yet.
SKU & packaging
Nominal sizes describe the product label; measured results are listed in each batch report. Published reports do not confirm the batch allocated to a future order.
Product & documentation questions
How do I read the size and pack quantity?
The per-vial size and number of vials per pack are listed separately in the table. The displayed price is for one pack. A blend’s stated size can describe combined ingredients; check its product label and report for individual components.
How do I find the matching COA?
Match the product, SKU and batch number with the published report. Open the batch page to read the actual results, original report and laboratory verification link. Ask support to confirm the allocated batch if it is not on your order.
Does a purity result mean every test passed?
No. Identity, purity, fill and endotoxin are separate measurements. Read each reported result and unit. An absent result is not a pass, and a less-than result is not zero.
Research Information
The blend is used to study how simultaneous amylin- and GLP-1-receptor signaling affects satiety, gastric emptying, glucose control and body-weight regulation in preclinical models, probing whether the two appetite pathways produce additive or synergistic effects. Supplied strictly for in-vitro and laboratory research use only — not for human or animal consumption.
Learn more
Read research overviews, COA verification guides, and reconstitution notes in our Knowledge Hub.